Toronto Dominion Bank
MDNA

Toronto Dominion Bank’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Toronto Dominion Bank’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,677
Closed -$495 – 1894
2023
Q3 		$495 Buy
1,677
+1,146
+216% +$445 ﹤0.01% 1503
2023
Q2 		$0 Buy
531
+54
+11% +$33 ﹤0.01% 1892
2023
Q1 		$0 Buy
+477
New +$297 ﹤0.01% 1787
2022
Q4 		– Sell
-2,100
Closed -$2K – 1627
2022
Q3 		$2K Sell
2,100
-27,003
-93% -$30.5K ﹤0.01% 1507
2022
Q2 		$33K Buy
29,103
+27,228
+1,452% +$29.1K ﹤0.01% 1162
2022
Q1 		$3K Buy
+1,875
New +$2.91K ﹤0.01% 1301
2021
Q2 		– Sell
-111
Closed – – 1542
2021
Q1 		$0 Hold
111
– – ﹤0.01% 1610
2020
Q4 		$1K Sell
111
-761
-87% -$3.07K ﹤0.01% 1333
2020
Q3 		$4K Buy
+872
New +$3.51K ﹤0.01% 1127

Other funds holding MDNA

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Toronto Dominion Bank's MDNA Position: Q4 2023 in Review

Toronto Dominion Bank sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 1,677 shares — an estimated $495 sold.

Toronto Dominion Bank first reported a position in MDNA in Q3 2020 and held it in 9 quarters. The position peaked at $33K in Q2 2022. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

  • Toronto Dominion Bank reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 1,677 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $495.
  • Toronto Dominion Bank first reported a position in Medicenna Therapeutics Corp. Common Shares in Q3 2020 and held it in 9 quarters.
  • Toronto Dominion Bank's Medicenna Therapeutics Corp. Common Shares position peaked at $33K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on Toronto Dominion Bank's 13F filing for Q4 2023, filed 13 Feb 2024.